Elad Walach is the co-founder and CEO of Aidoc, a leading clinical AI platform that supports care for more than 45 million patients annually across 150+ health systems and holds the most FDA clearances in its category. Under his leadership, Aidoc has grown from an early-stage startup into a category-defining company that partners with health systems to implement AI at enterprise scale, with a focus on improving clinical outcomes, accelerating time-to-treatment, and increasing system-wide efficiency.

Elad’s experience spans both deep technical expertise and strategic collaboration with some of the largest health systems in the country. His background in deploying mission-critical technologies—first as a leader in the Israeli Air Force and now in complex healthcare environments—has shaped his commitment to responsible, clinically validated AI that delivers real-world impact.

Recognized by Modern Healthcare's 40 Under 40 and Forbes' 30 Under 30, Elad is a frequent advisor to health system executives and brings a unique perspective on governance, deployment, and long-term sustainability of AI infrastructure. His work has been recognized globally, and he regularly contributes to discussions on the future of healthcare innovation at leading industry forums. His mission is clear: to harness the power of AI to deliver faster, more accurate clinical insights that improve patient outcomes and redefine what is possible in modern medicine.